Compared to the non-tumor tissues, the expression levels of both IRF-1 and MFNG were significantly lower in 11 types of sarcoma including leiomyosarcoma, myxoid/round cell liposarcoma, and malignant fibrous histiocytoma. This evidence concerns the gene IRF1 and sarcoma.